Complexation of histone deacetylase inhibitor belinostat to Cu(II) prevents premature metabolic inactivation in vitro and demonstrates potent anti-cancer activity in vitro and ex vivo in colon cancerEllen Finnegan, Sudipto Das, Gráinne Kirwan et al.|Cellular Oncology|2023Cited by 7
Mo1219 EPIGENETICALLY REGULATED GENE ENHANCERS AS NOVEL RATIONAL THERAPEUTIC TARGETS TO IMPEDE COLORECTAL CANCER PROGRESSIONXinxin Shao, Sudipto Das, Ellen Finnegan et al.|Gastroenterology|2024Cited by 0
Abstract 7181: Gene enhancers as novel rationale therapeutic targets for impeding colorectal cancer progressionFlavia Genua, Sudipto Das, Xinxin Shao et al.|Cancer Research|2025Cited by 0